smpСкорая медицинская помощьEMERGENCY MEDICAL CARE2072-6716Northwest State Medical University named after II Mechnikov10.24884/2072-6716-2020-21-4-70-76smp-450Research ArticleОБЗОРЫREVIEWSТРОМБОЛИТИЧЕСКАЯ ТЕРАПИЯ ПРИ ОСТРОМ ИНФАРКТЕ МИОКАРДА НА ДОГОСПИТАЛЬНОМ ЭТАПЕ: КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ И РЕАЛЬНАЯ ПРАКТИКАTHROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION AT THE PREHOSPITAL STAGE: CLINICAL GUIDELINES AND REAL PRACTICEШальневВ. И.ShalnevV. I.

Шальнев Владимир Ильич — доктор медицинских наук, профессор кафедры скорой медицинской помощи 

191015, СанктПетербург, Кирочная ул., д.41

St. Petersburg

VISSZGMU@yandex.ruСеверо-Западный государственный медицинский университет им. И. И. МечниковаРоссияNorth-Western State Medical University named after I. I. MechnicovRussian Federation2020200120212147076Copyright © Шальнев В.И., 20212021Шальнев В.И.Shalnev V.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://smp.spb.ru/jour/article/view/450

В статье анализируются современные подходы к проведению системной тромболитической терапии при остром инфаркте миокарда на догоспитальном этапе лечения. Освещаются результаты наиболее важных клинических исследований и регистров по данной теме. Обсуждаются последние международные и отечественные клинические рекомендации по тромболитической терапии и фармакоинвазивной стратегии в терапии острого инфаркта миокарда.

The article highlights the modern approach to the thrombolytic therapy of acute myocardial infarction at the prehospital stage. The results of most significant clinical trials and registers in this area are discussed. Recent international and Russian clinical guidelines on thrombolytic therapy and pharmacoinvasive strategy in the treatment of acute myocardial infarction are also highlighted.

острый инфаркт миокардатромболизисреперфузия миокардафармакоинвазивная стратегияacute myocardial infarctionthrombolytic therapyreperfusionpharmacoinvasive strategyReferencesShroeder R. Systemic versus intracoronary streptokinase infusion in the treatment of acute myocardial infarction // J. Am. Coll. Cardiology. 1983. Vol. 5. P. 1254–1261. doi: 10.1016/s0735–1097(83)80137–5.Shroeder R. Systemic versus intracoronary streptokinase infusion in the treatment of acute myocardial infarction // J. Am. Coll. Cardiology. 1983. Vol. 5. P. 1254–1261. doi: 10.1016/s0735–1097(83)80137–5.Shroeder R., Biamino G., Leitner R. et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction // Circulation. 1983. Vol. 67. P. 536–548.Shroeder R., Biamino G., Leitner R. et al. Intravenous short-term infusion of streptokinase in acute myocardial infarction // Circulation. 1983. Vol. 67. P. 536–548.Andersson J. L., Marshall H. W., Askins J. C. et al. A randomized trial of intracoronary and intravenous streptokinase in acute myocardial infarction // Circulation. 1984. Vol. 70. P. 606–618.Andersson J. L., Marshall H. W., Askins J. C. et al. A randomized trial of intracoronary and intravenous streptokinase in acute myocardial infarction // Circulation. 1984. Vol. 70. P. 606–618.Spann J. F., Sherry S., Carabello B. A. et al. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies // Am. J. Cardiology. 1984. Vol. 53. P. 655–661.Spann J. F., Sherry S., Carabello B. A. et al. Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies // Am. J. Cardiology. 1984. Vol. 53. P. 655–661.MacLennan B.A., McMaster A., Webb S. W. et al. High dose intravenous streptokinase in acute myocardial infarction: short and long term prognosis // Brit. Heart J. 1986. Vol. 55. P. 231–239. doi: 10.1136/ hrt.55.3.231.MacLennan B.A., McMaster A., Webb S. W. et al. High dose intravenous streptokinase in acute myocardial infarction: short and long term prognosis // Brit. Heart J. 1986. Vol. 55. P. 231–239. doi: 10.1136/ hrt.55.3.231.SAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction. Mortality, morbidity and infarct size at 21 days // N. Engl. J. Med. 1986. Vol. 314. P. 1465–1471.SAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction. Mortality, morbidity and infarct size at 21 days // N. Engl. J. Med. 1986. Vol. 314. P. 1465–1471.Morrison L. J., Verbeek P. R., McDonald A. C. et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis // JAMA. 2000. Vol. 283. P. 2686–2692.Morrison L. J., Verbeek P. R., McDonald A. C. et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis // JAMA. 2000. Vol. 283. P. 2686–2692.Morrow D. A., Antman E. M., Sayah A. et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial // J. Am. Coll. Cardiol. 2002. Vol. 40 (1). P. 71–77.Morrow D. A., Antman E. M., Sayah A. et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial // J. Am. Coll. Cardiol. 2002. Vol. 40 (1). P. 71–77.Nilsen J. M., Bo I., Rasmussen J. R. et al. Doubled survival from out-of-hospital cardiac arrest in a rural community in North-Norway following implementation of an aggressive chest pain protocol with early prehospital thrombolysois for STEMI // Circulation. 2011. Vol. 124 (Suppl. 21). P. A17087.Nilsen J. M., Bo I., Rasmussen J. R. et al. Doubled survival from out-of-hospital cardiac arrest in a rural community in North-Norway following implementation of an aggressive chest pain protocol with early prehospital thrombolysois for STEMI // Circulation. 2011. Vol. 124 (Suppl. 21). P. A17087.Шальнев В. И., Дерягина Г. П. Опыт применения стрептодеказы в остром периоде инфаркта миокарда // Клиническая медицина. 1986. № 7. C. 41–46.Shalnev V. I., Deryagina G. P. Experience of using streptodecase in the acute period of myocardial infarction. Clinical medicine, 1986, No 7, pp. 41–46 (In Russ.).Шальнев В. И., Ганелина И. Е., Дерягина Г. П. и дp. Ранняя системная тромболитическая терапия при остром инфаркте миокарда // Острые формы коронарной недостаточности в клинике и эксперименте. Л.: Наука, 1988. С. 185–192.Shalnev V. I., Ganelina I. E., Deryagina G. P. Early systemic thrombolytic therapy in acute myocardial infarction. Acute forms of coronary insufficiency in clinic and experiment. Leningrad: Nauka, 1988, pp. 185–192 (In Russ.).Ганелина И. Е., Варшавский С. Ю., Шальнев В. И и др. Системная тромболитическая терапия стептокиназой на догоспитальном этапе лечения острого инфаркта миокарда // Терапевтический архив. 1992. № 3. C. 86–90.Ganelina I. E., Varshavsky S. Y., Shalnev V. I. et al. Systemic thrombolytic therapy with steptokinase at the prehospital stage of treatment of acute myocardial infarction. Therapeutic archive, 1992, No 3, pp. 86–90 (In Russ.).Шальнев В. И. Влияние системной тромболитической терапии на сократительную функцию миокарда и толерантность к физической нагрузке у больных острым инфарктом миокарда // Терапевтический архив. 1996. № 5. C. 52–56.Shalnev V. I. The effect of systemic thrombolytic therapy on myocardial contractile function and exercise tolerance in patients with acute myocardial infarction. Therapeutic archives, 1996, No. 5, pp. 52–56 (In Russ.).Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. 2003. Vol. 361. P. 13–20. doi: 10.1016/S0140–6736(03)12113–7.Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. 2003. Vol. 361. P. 13–20. doi: 10.1016/S0140–6736(03)12113–7.Gershlick A. H., Stephens-Lloyd A., Hughes S. et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction // N. Engl. J. Med. 2005. Vol. 353. P. 2758–2768.Gershlick A. H., Stephens-Lloyd A., Hughes S. et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction // N. Engl. J. Med. 2005. Vol. 353. P. 2758–2768.Roule V., Ardouin P., Blanchart K. et al. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials // Crit. Care. 2016. Vol. 20. P. 359–365.Roule V., Ardouin P., Blanchart K. et al. Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials // Crit. Care. 2016. Vol. 20. P. 359–365.Ibanez B., Agawall S., Antunes M. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology // Eur. Heart J. 2018. Vol. 39. P. 119–177. doi: 10.1093/eurheart/ehj393.Ibanez B., Agawall S., Antunes M. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology // Eur. Heart J. 2018. Vol. 39. P. 119–177. doi: 10.1093/eurheart/ehj393.Острый инфаркт миокарда с подъемом сегмента ST на ЭКГ. Клинические рекомендации. Российское кардиологическое общество, 2020. Доступно на сайте РКО // https: scardio.ru/ клинические рекомендации.Acute myocardial infarction with ST segment elevation on ECG. Clinical guidelines. Russian Society of Cardiology, 2020. Available on the website RKO, https: scardio.ru. Klinitcheskie rekomendatsii (In Russ.).Аrmstrong P. W., Gershlick A. H., Goldstein P. et al. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction // New Engl. J. Med. 2013. Vol. 368. P. 1379–1387.Аrmstrong P. W., Gershlick A. H., Goldstein P. et al. Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction // New Engl. J. Med. 2013. Vol. 368. P. 1379–1387.Welsh R. C., Goldstein P., Sinnaeve P. et al. Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the STREAM study // Eur. Heart J. Acute Cardiovasc. Care. 2017. Epub. ahead of print 1 June 2017. doi: 10.1177/204.887.2617700872.Welsh R. C., Goldstein P., Sinnaeve P. et al. Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the STREAM study // Eur. Heart J. Acute Cardiovasc. Care. 2017. Epub. ahead of print 1 June 2017. doi: 10.1177/204.887.2617700872.Bonnefoy E., Steg P. G., Boutitie F. et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up // Eur. Heart J. 2009. Vol. 30. P. 1598–1606.Bonnefoy E., Steg P. G., Boutitie F. et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up // Eur. Heart J. 2009. Vol. 30. P. 1598–1606.Danchin N., Puymirat E., Steg P. G. et al. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and NonST-Elevation Myocardial Infarction (FAST-MI) // Circulation. 2014. Vol. 129. P. 1629–1636.Danchin N., Puymirat E., Steg P. G. et al. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and NonST-Elevation Myocardial Infarction (FAST-MI) // Circulation. 2014. Vol. 129. P. 1629–1636.Mannsverk J., Steigen T., Wang H. et al. Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic Norway // Eur. Heart J. Acute Cardiovasc. Care. 2019. Vol. 8 (1). P. 8–14.Mannsverk J., Steigen T., Wang H. et al. Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic Norway // Eur. Heart J. Acute Cardiovasc. Care. 2019. Vol. 8 (1). P. 8–14.Scholz K. H., Maier S. K. Maier L. S. et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial // Eur. Heart J. 2018. Vol. 39. P. 1065–1074.Scholz K. H., Maier S. K. Maier L. S. et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial // Eur. Heart J. 2018. Vol. 39. P. 1065–1074.Wong G., Welsford M., Ainsworth C. et al. 2019 Canadian Cardiovascular Society and Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Segment Elevation Myocardial Infarction. Focused Update on Reperfusion // Canadian Journal of Cardiology. 2019. Vol. 35. P. 107–132.Wong G., Welsford M., Ainsworth C. et al. 2019 Canadian Cardiovascular Society and Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Segment Elevation Myocardial Infarction. Focused Update on Reperfusion // Canadian Journal of Cardiology. 2019. Vol. 35. P. 107–132.

The authors declare that there are no conflicts of interest present.